期刊文献+

新精神活性物质药理作用研究进展

Research progress on pharmacological effects of new psychoactive substances
下载PDF
导出
摘要 新精神活性物质是近几年开始流行的新型滥用物质,比起传统毒品来说其种类更丰富、化学结构更复杂。新精神活性物质按照药理学作用可分为七大类,除了效果未知的类别,其余的兴奋剂类、合成大麻素受体激动剂类、经典致幻剂类、合成阿片类、身心分离剂类和镇静催眠类都可通过与特异性受体结合从而发挥作用。该文对新精神活性物质的药理作用及其机制进行综述,以期为新精神活性物质的研究提供参考。 As the newly abused drugs,new psychoactive substances(NPS)are more diverse and complex in chemical structure than traditional drugs.According to the pharmacological effects,NPS can be divided into seven categories including stimulants,synthetic opioids,synthetic cannabinoid receptor agonists,dissociatives,classic hallucinogens,sedatives/hypnotics and others.Except for those with unknown effects,they all exert pharmacological effects by the interaction with specific receptors.In this paper,the pharmacological effects and mechanism of actions are reviewed in order to provide reference for the research of NPS.
作者 李香豫 陈园园 乔艳玲 李楠 许雅雯 曾宪斌 徐鹏 LI Xiang-yu;CHEN Yuan-yuan;QIAO Yan-ling;LI Nan;XU Ya-wen;ZENG Xian-bin;XU Peng(Key Laboratory of Drug Monitoring and Control,Drug Intelligence and Forensic Center,Ministry of Public Security,Beijing 100193,China;Office of China National Narcotics Control Commission-China Pharmaceutical University Joint Laboratory on Key Technologies of Narcotics Control,Beijing 100193,China;School of Pharmacy,China Pharmaceutical University,Nanjing 210009,China)
出处 《中国药理学通报》 CAS CSCD 北大核心 2024年第4期630-636,共7页 Chinese Pharmacological Bulletin
基金 国家自然科学基金重点项目(No 82130056)。
关键词 新精神活性物质 兴奋剂类 合成大麻素受体激动剂类 经典致幻剂类 合成阿片类 身心分离剂类 镇静催眠类 作用机制 new psychoactive substances stimulants synthetic cannabinoid receptor agonists classic hallucinogens synthetic opioids dissociatives sedatives/hypnotics mechanism of actions
  • 相关文献

参考文献4

二级参考文献69

  • 1李俊旭.致幻剂[J].中国药物依赖性杂志,2007,16(4):249-254. 被引量:3
  • 2Cooper M E, Regnell S E. The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake [ J]. Br J Clin Pharmacol, 2013, [ Epub ahead of print].
  • 3Battista N, Di Tommaso M, Maccarrone M, et al. The endocanna- binoid system: an overview [ J ]. Frontiers in Behavioral Neuro- science, 2012, 6:1 -7.
  • 4Muccioli G G. Endocannabinoid biosynthesis and inactivation, from simple to complex [J]. Drug Discov Today, 2010, 15:474 -83.
  • 5Shohami E, Cohen-Yeshurun A, Magid L, et al. Endocannabi- noids and traumatic brain injury [J]. Br J Pharmacol, 2011, 163 : 1402 - 10.
  • 6Astarita G, Ahmed F, Piomelli D. Identification of biosynthetic precursors for the endoeannabinoid anandamide in the rat brain [J]. J Lipid Res , 2008, 49:48-57.
  • 7Tsuboi K, Ikematsu N, Uyama T, et al. Biosynthetic pathways of bioactive N-acylethanolamines in brain [ J ~. CNS Neurol Disord Drug Target, 2013, 12 ( 1 ) : 7 - 16.
  • 8Simon G M, Gravatt B F. Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glyeerolphospho-N- acyl ethanolamine precursors on mouse brain [ J ]. J Biol Chem, 2008, 283 : 9341 - 9.
  • 9Liu J, Wang L, Harvey-White J, et al. Multiple pathways in- volved in the biosynthesis of anandamide [ J ]. Neuropharmacol, 2008, 54(1): 1-7.
  • 10Kano M, Ohno-Shosaku T, Hashimotodani Y, et al. Endocannab- inoid-mediated control of synaptic transmission [ J]. Physiol Rev, 2009, 89 ( 1 ) : 309 - 80.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部